SCIESCOPUSQ4
BIOPHARM INTERNATIONAL
ADVANSTAR COMMUNICATIONS INC, United States
BIOPHARM INTERNATIONAL is an academic journal published by ADVANSTAR COMMUNICATIONS INC (United States). Identifiers: ISSN 1542-166X, eISSN 1939-1862. Indexed in SCIE, SCOPUS. Metrics: JIF 0.2, CiteScore 0.3, SJR 0.136, SNIP 0.16. Subject areas: BIOTECHNOLOGY & APPLIED MICROBIOLOGY, PHARMACOLOGY & PHARMACY. tlooto lists 416 papers from this journal.
CiteScore
0.30
Scopus citation metric
SJR
0.136
SCImago rank
SNIP
0.16
Source normalized impact
Percentage rank
-
JIF percentile rank
Journal profile
- ISSN
- 1542-166X
- eISSN
- 1939-1862
- Abbreviation
- BIOPHARM INT
- Publisher
- ADVANSTAR COMMUNICATIONS INC
- Country
- United States
Web of Science categories
SCIEBIOTECHNOLOGY & APPLIED MICROBIOLOGY, PHARMACOLOGY & PHARMACY
Scopus ASJC categories
1305 Biotechnology3003 Pharmaceutical Science
Keywords
Biotechnology & Applied Microbiology | Pharmacology & Pharmacy
Papers in this journal
Recent papers
- The call for a rapid response
2020
- Will COVID-19 pandemic finally establish drug quality metrics?: Drug shortages and supply chain challenges bolster fda efforts to promote modern manufacturing
2020
- The (Dis)information pandemic
2020
- Pandemic spurs efforts to boost pharma manufacturing in US
2020
- Biopharma’s leadership role in a pandemic
2020
Most cited papers
- The development report
2004 · 153 citations
- A risk-based approach to immunogenicity concerns of therapeutic protein products: Part 2. Considering host-specific and product-specific factors impacting immunogenicity
2004 · 83 citations
- Elements of Quality by Design in Development and Scale-Up of Freeze-Dried Parenterals
2008 · 79 citations
- A risk-based approach to immunogenicity concerns of therapeutic protein product, Pat III
2004 · 62 citations
- Process chromatography : Five decades of innovation
2007 · 54 citations